Similar articles for PMID: 20810727

Year	Number of Results
1993	1
1995	1
1996	1
1999	1
2002	4
2003	1
2004	1
2005	2
2006	4
2007	6
2008	5
2009	4
2010	9
2011	7
2012	4
2013	4
2014	3
2015	9
2016	6
2017	5
2018	5
2019	4
2020	10
2021	4
2024	0

1

CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.

Miura S, Kawana K, Schust DJ, Fujii T, Yokoyama T, Iwasawa Y, Nagamatsu T, Adachi K, Tomio A, Tomio K, Kojima S, Yasugi T, Kozuma S, Taketani Y. Miura S, et al. J Virol. 2010 Nov;84(22):11614-23. doi: 10.1128/JVI.01053-10. Epub 2010 Sep 1. J Virol. 2010. PMID: 20810727 Free PMC article.

2

Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.

Raikhy G, Woodby BL, Scott ML, Shin G, Myers JE, Scott RS, Bodily JM. Raikhy G, et al. J Virol. 2019 Sep 12;93(19):e00458-19. doi: 10.1128/JVI.00458-19. Print 2019 Oct 1. J Virol. 2019. PMID: 31292244 Free PMC article.

3

Evasion of host immune defenses by human papillomavirus.

Westrich JA, Warren CJ, Pyeon D. Westrich JA, et al. Virus Res. 2017 Mar 2;231:21-33. doi: 10.1016/j.virusres.2016.11.023. Epub 2016 Nov 24. Virus Res. 2017. PMID: 27890631 Free PMC article. Review.

4

The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Sudarshan SR, Schlegel R, Liu X. Sudarshan SR, et al. Biochem Biophys Res Commun. 2010 Sep 3;399(4):617-22. doi: 10.1016/j.bbrc.2010.07.125. Epub 2010 Aug 3. Biochem Biophys Res Commun. 2010. PMID: 20688044 Free PMC article.

5

hrHPV E5 oncoprotein: immune evasion and related immunotherapies.

de Freitas AC, de Oliveira THA, Barros MR Jr, Venuti A. de Freitas AC, et al. J Exp Clin Cancer Res. 2017 May 25;36(1):71. doi: 10.1186/s13046-017-0541-1. J Exp Clin Cancer Res. 2017. PMID: 28545552 Free PMC article. Review.

6

Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.

Cisneros-Ramírez D, Martínez-Laguna Y, Martínez-Morales P, Aguilar-Lemarroy A, Jave-Suárez LF, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V. Cisneros-Ramírez D, et al. Mol Med Rep. 2020 Dec;22(6):5444-5453. doi: 10.3892/mmr.2020.11630. Epub 2020 Oct 23. Mol Med Rep. 2020. PMID: 33174037 Free PMC article.

7

Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.

Sasagawa T, Takagi H, Makinoda S. Sasagawa T, et al. J Infect Chemother. 2012 Dec;18(6):807-15. doi: 10.1007/s10156-012-0485-5. Epub 2012 Nov 3. J Infect Chemother. 2012. PMID: 23117294 Review.

8

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Miyauchi S, Sanders PD, Guram K, Kim SS, Paolini F, Venuti A, Cohen EEW, Gutkind JS, Califano JA, Sharabi AB. Miyauchi S, et al. Cancer Res. 2020 Feb 15;80(4):732-746. doi: 10.1158/0008-5472.CAN-19-1771. Epub 2019 Dec 17. Cancer Res. 2020. PMID: 31848196 Free PMC article.

9

Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.

Ashrafi GH, Brown DR, Fife KH, Campo MS. Ashrafi GH, et al. Virus Res. 2006 Sep;120(1-2):208-11. doi: 10.1016/j.virusres.2006.02.005. Epub 2006 Jun 15. Virus Res. 2006. PMID: 16780984

10

HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

Campo MS, Graham SV, Cortese MS, Ashrafi GH, Araibi EH, Dornan ES, Miners K, Nunes C, Man S. Campo MS, et al. Virology. 2010 Nov 10;407(1):137-42. doi: 10.1016/j.virol.2010.07.044. Virology. 2010. PMID: 20813390 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year